Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways
In Vitro Cellular & Developmental Biology - Animal · 2025
DOI: 10.1007/s11626-024-01008-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, 2025. Verfasst von Makoto Yanoshita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2…. Hauptthemen laut MEDLINE: Synoviocytes, Docosahexaenoic Acids, Proto-Oncogene Proteins c-akt, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI Grant, Hiroshima University.
Abstract (Originalsprache)
Synovitis represents the initial pathological change in osteoarthritis and contributes to its progression. Resolvin D1 (RV-D1) is a novel and endogenous docosahexaenoic acid-derived lipid mediator, which regulates the duration and magnitude of inflammation by downregulating pro-inflammatory genes and mediators. However, the effects of RV-D1 on synovitis remain unknown. The aim of the present study was to investigate the anti-inflammatory effects of RV-D1 in human fibroblast-like synoviocytes (HFLSs) and the underlying mechanisms. The expression of the HFLS formyl peptide receptor 2 (ALX/FPR) was examined via immunocytochemical analysis. HFLSs were treated with 1 ng/mL recombinant human interleukin-1β (IL-1β) and RV-D1. The gene expression of interleukin-1β ( IL1B ), matrix metalloproteinase 3 ( MMP3 ), and MMP13 was examined using real-time reverse transcription-polymerase chain reaction after treatment with IL-1β and RV-D1. The effect of RV-D1 on apoptosis was examined based on fluorescence intensity. Phosphorylation of p-38, extracellular signal-regulated kinase, c-Jun N-terminal kinase, nuclear factor kappa B (NF-κB), and AKT was analyzed via western blotting. ALX/FPR staining was observed on the cell surface. RV-D1 significantly suppressed the IL-1β-induced increase in gene and protein expression of IL-1β, MMP-3, and MMP-13. Pretreatment with 100 nM RV-D1 significantly increased the fluorescence intensity compared to that in the non-treatment group. Furthermore, pretreatment with RV-D1 significantly suppressed the phosphorylation of p-38, NF-κB, and AKT. Whereas WRW4, an antagonist of ALX/ FPR2, treatment weakened the effect of RV-D1, resulting in p-38, NF-κB, and AKT phosphorylation and the protein expression of MMP-13 at levels comparable to those in the IL-1β without RV-D1. In conclusion, RV-D1 suppressed IL-1β and MMP expression by inhibiting the phosphorylation of p-38, NF-κB, and AKT in inflammation in HFLSs. RV-D1 can be used to develop treatments for osteoarthritis and other inflammatory disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3 Minami-Ku, Hiroshima-Shi, Hiroshima Prefecture, Japan.
- Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3 Minami-Ku, Hiroshima-Shi, Hiroshima Prefecture, Japan. hirose@hiros…
Förderung
- Japan Society for the Promotion of Science KAKENHI Grant
- Hiroshima University
Zitieren
APA
Yanoshita, M., Hirose, N., Nishiyama, S., Tsuboi, E., Kubo, N., Kita, D., & Tanimoto, K. (2025). Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways. In Vitro Cellular & Developmental Biology - Animal. https://doi.org/10.1007/s11626-024-01008-9
Vancouver
Yanoshita M, Hirose N, Nishiyama S, Tsuboi E, Kubo N, Kita D, et al. Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways. In Vitro Cellular & Developmental Biology - Animal. 2025. doi:10.1007/s11626-024-01008-9
BibTeX
@article{Yanoshita2025,
author = {Yanoshita, Makoto and Hirose, Naoto and Nishiyama, Sayuri and Tsuboi, Eri and Kubo, Naoki and Kita, Daiki and Tanimoto, Kotaro},
title = {Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways},
journal = {In Vitro Cellular & Developmental Biology - Animal},
year = {2025},
doi = {10.1007/s11626-024-01008-9}
}
EUVIMED